Characterization of Alginate/Silver Nanobiocomposites Synthesized by Solution Plasma Process and Their Antimicrobial Properties

Figure 6

CFU reduction of the pathogens by the AL/AgNP biocomposites. CFU reductions as a function of the AgNP concentration exhibited decrease in the viable cells as the AgNP concentration increased.